Impact Factor
4.58
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.49
11,380 total citations
h5-index
85
h5 depth signal
Cited share
89.2%
1,717 of 1,925
Total citations
11,380
Citation footprint
Metric signal
6.03
External metric anchor
Self-citation
3.5%
397 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
2,533
United States
935
United Kingdom
839
Germany
584
Australia
507
Citing Fields of Research
Psychiatry
5,728
Psychiatry & Psychology
2,792
Neurosciences
728
Neurodevelopmental Disorders
534
Substance Abuse
401
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
10,207
Articles tracked across the journal lifetime
Indexed publication set
1,925
1,717 cited publications
Last 12 months
1,328
110.7 publications/month
Open access share
100.0%
1,328 OA publications in the last year
Leading citing country
China
2,533 citing publications
Leading citing field
Psychiatry
5,728 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v1, 2001-
v1, 2001-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Psychiatry
Broad Categories
Psychiatry
Psychiatry
MeSH Descriptors
Mental Disorders
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
04
05
DOI 10.1186/s12888-026-08767-7
Open DOI
Amygdala neurofeedback as an adjunct to residential dialectical behavior therapy for borderline personality disorder: a pilot randomized controlled trial
Background: Borderline personality disorder (BPD) is characterized by affective instability and amygdala hyperreactivity. Although dialectical behavior therapy (DBT) reduces symptoms and amygdala-related abnormalities, many patients show...
06
DOI 10.1186/s12888-026-08687-6
Open DOI
Previous psychiatric diagnoses preceding a first recorded schizophrenia diagnosis and subsequent clinical outcomes: a retrospective study using a Japanese claims database
Background: Schizophrenia is a heterogeneous disorder in which affective symptoms commonly occur before the onset of frank psychosis. Depressive and anxiety symptoms preceding schizophrenia may complicate early diagnosis and influence su...
07
08
DOI 10.1186/s12888-026-08759-7
Open DOI
The impact of psychostimulants on sleep in ADHD adults: a randomized cross-over trial
Purpose: Attention-Deficit/Hyperactivity Disorder (ADHD) is a highly prevalent neurodevelopmental disorder affecting both pediatric and adult populations. Stimulant medications (STM) including methylphenidate (MPH) or lisdexamfetamine (L...
09
DOI 10.1186/s12888-026-08751-1
Open DOI
Clinical validation of a composite medical device combining blood biomarkers, a decision algorithm, and the Mood Disorder Questionnaire to support the differential diagnosis of bipolar disorder in primary-care patients with a major depressive episode: a study protocol
Background: Bipolar disorder is common, highly disabling and frequently misdiagnosed as unipolar depression in primary care, leading to inappropriate antidepressant treatment and substantial diagnostic delays. Early and accurate identifi...
10
DOI 10.1186/s12888-026-08628-3
Open DOI
Adjunctive ketamine for affective symptoms, craving, and relapse prevention in opioid use disorder: protocol for a randomised, double-blind, placebo-controlled clinical trial
Background: Opioid use disorder (OUD) is a chronic relapsing condition associated with substantial mortality. Although medications for opioid use disorder (MOUD) can be effective in reducing opioid use and improving treatment outcomes, r...
Bibliographical & Catalog Notes
Title from BioMed Central archive volume screen (viewed on Feb. 20, 2002).
Articles are added consecutively to the current annual v.
Text (electronic journal) in HTML and PDF formats.
Mode of access: Internet.